Opilo 125 mg /80 mg Capsule

About Opilo 125 mg /80 mg Capsule

Opilo 125 mg/80 mg capsules are an effective medication classified as a neurokinin-1 antagonist, primarily used to manage and prevent nausea and vomiting associated with chemotherapy. This innovative treatment works by blocking the action of substance P, a neuropeptide that plays a crucial role in triggering these distressing symptoms. By inhibiting substance P, Opilo helps patients maintain a better quality of life during cancer treatment, allowing for improved tolerance of chemotherapy regimens. It's important to note that while Opilo is beneficial, it may cause side effects such as dizziness or fatigue in some individuals, so close monitoring is advised. Patients with a history of hypersensitivity to the components of the medication should avoid its use. Additionally, those who are pregnant or breastfeeding should consult their healthcare provider before starting Opilo. Overall, Opilo 125 mg/80 mg capsules represent a significant advancement in supportive cancer care, enhancing patients' ability to undergo treatment with greater comfort and fewer interruptions.